secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2025-10-20T23:59:59+00:00
Accession:  0001628280-25-045513
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics regains Nasdaq minimum bid price compliance
----------------------------------------------------------------

- Received Nasdaq letter on Oct 17, 2025 confirming compliance regained after 10 consecutive business days with closing bid price at or above $1.00.
- Company had been noncompliant since Feb 27, 2025; granted extension to Feb 23, 2026.
- Nasdaq considers the matter closed; delisting risk removed.
- Stock ticker CNTX trades on Nasdaq under Minimum Bid Price Rule 5550(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000162828025045513/0001628280-25-045513-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000162828025045513/cntx-20251017.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-045513

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer